This project is supported by the Brazilian subsidiary of L'OCCITANE en Provence.


Congenital cataract and retinopathy of prematurity (both treatable) are the leading causes of blindness in Latin America, accounting for approximately 40% of cases. Faced with this situation, the prevention of avoidable and curable blindness is one of the objectives of the global proposals of the WHO (World Health Organization) in the field of vision.


Supported Project

In 2023-2024, the Brazilian subsidiary of L'OCCITANE en Provence supports Caviver and its  Blindness Prevention Program which is intended for the care and monitoring of children and adolescents, between 0 and 15 years of age, through the provision of social,clinical,surgical and rehabilitation care for cases of congenital cataract, congenital glaucoma and retinopathy of prematurity in the state of Ceara.

Some Figures

Budget 20.893,19 euros

Goal 400 beneficiaries

Goal 100 new actors trained